Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: Evidence from a long-term controlled trial.
J Diabetes Complications
; 28(5): 742-9, 2014.
Article
in En
| MEDLINE
| ID: mdl-24856612
Full text:
1
Database:
MEDLINE
Main subject:
Insulin, Long-Acting
/
Diabetes Mellitus, Type 2
/
Hypoglycemia
/
Hypoglycemic Agents
/
Insulin, Isophane
Type of study:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Diabetes Complications
Journal subject:
ENDOCRINOLOGIA
Year:
2014
Type:
Article